Encyclopedia of Cancer

Living Edition
| Editors: Manfred Schwab

Mcl-1

  • Klaus Podar
Living reference work entry
DOI: https://doi.org/10.1007/978-3-642-27841-9_7232-1

Definition

Myeloid cell leukemia-1 (Mcl-1) is an antiapoptotic member of the Bcl-2 protein family and plays an integral role in cell survival and apoptosis. Mcl-1 is characterized by its short half-life, its wide intracellular localization, and the tight regulation of its transcription, translation, and degradation.

Characteristics

Structurally, Mcl-1 is unique among the Bcl-2 family. As other antiapoptotic Bcl-2 family proteins, Mcl-1 contains Bcl-2 homology regions (BH1-4 domains) and a transmembrane domain, which confer the ability to heterodimerize with other family members (e.g., proapoptotic proteins Bak and Bax) or to bind to membranes (e.g., cell membrane, mitochondrial membrane, nuclear envelope). Mcl-1 differs from its pro-survival family members in its larger size of 350 residues due to the presence of two polypeptide sequences enriched in proline (P), glutamic acid (E), serine (S), and threonine (T) (PEST). PEST regions are made responsible for Mcl-1 degradation via the...

Keywords

Multiple Myeloma Proapoptotic Protein Increase Tumor Cell Survival 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

References

  1. Del Gaizo Moore V, Letai A (2013) BH3 profiling – measuring integrated function of the mitochondrial apoptotic pathway to predict cell fate decisions. Cancer Lett 332(2):202CrossRefPubMedGoogle Scholar
  2. Opferman JT (2015) Attacking cancer’s Achilles heel: antagonism of anti-apoptotic BCL-2 family members. FEBS JGoogle Scholar
  3. Perciavalle RM, Opferman JT (2013) Delving deeper: MCL-1’s contributions to normal and cancer biology. Trends Cell Biol 23(1):22–29CrossRefPubMedGoogle Scholar
  4. Quinn BA, Dash R, Azab B et al (2011) Targeting Mcl-1 for the therapy of cancer. Exp Opin Investig Drugs 20(10):1397–1411CrossRefGoogle Scholar
  5. Thomas LW, Lam C, Edwards SW (2010) Mcl-1; the molecular regulation of protein function. FEBS Lett 584(14):2981–2989CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  1. 1.Medical Oncology, National Center for Tumor Diseases (NCT)University of HeidelbergHeidelbergGermany